Antigen-specific induction of peripheral T cell tolerance in vivo by codelivery of DNA vectors encoding antigen and Fas ligand

被引:19
作者
Georgantas, RW
Leong, KW
August, JT
机构
[1] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA
[2] Johns Hopkins Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA
关键词
D O I
10.1089/10430340050015464
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Fas ligand (FasL, CD95L) induces apoptosis in activated T cells with upregulated Fas (CD95) expression through the process termed activation-induced cell death (AICD), We postulated that coexpression of antigen and Fast within individual antigen-presenting cells would lead to antigen-specific activation of T cells and to their consequent deletion by Fast-mediated AICD, A DNA-gelatin coacervate containing transferrin cell ligand, calcium, and the lysosomatropic agent chloroquine, a formulation previously shown to achieve high-level transfection of immune and muscle cells in vivo, was used to codeliver plasmids encoding Fast and antigen, Mice developed a strong cytolytic T cell response to beta-Gal when injected with DNA encoding beta-galactosidase (LacZ) model antigen, either as naked DNA or DNA nanoparticles, but failed to respond when there was concomitant injection of nanoparticles containing both the LacZ and murine Fast DNA vectors, This loss of T cell response was systemic, specific for beta-Gal, complete when nonoparticles were administered before antigen challenge, and decreased the T cell response: from prior immunization with LacZ DNA, In effect, this "tolerization" injection induced antigen-specific peripheral tolerance in study mice, and represents a possible approach to the treatment of autoimmuue diseases and transplantation rejection.
引用
收藏
页码:851 / 858
页数:8
相关论文
共 52 条
  • [1] DNA vaccination: Transfection and activation of dendritic cells as key events for immunity
    Akbari, O
    Panjwani, N
    Garcia, S
    Tascon, R
    Lowrie, D
    Stockinger, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (01) : 169 - 177
  • [2] FAS LIGAND MEDIATES ACTIVATION-INDUCED CELL-DEATH IN HUMAN T-LYMPHOCYTES
    ALDERSON, MR
    TOUGH, TW
    DAVISSMITH, T
    BRADDY, S
    FALK, B
    SCHOOLEY, KA
    GOODWIN, RG
    SMITH, CA
    RAMSDELL, F
    LYNCH, DH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) : 71 - 77
  • [3] Thymus, thymoma, and specific T cells in myasthenia gravis
    Beeson, D
    Bond, AP
    Corlett, L
    Curnow, SJ
    Hill, ME
    Jacobson, LW
    Maclennan, C
    Meager, A
    Moody, AM
    Moss, P
    Nagvekar, N
    Newsom-Davis, J
    Pantic, N
    Roxanis, I
    Spack, EG
    Vincent, A
    Willcox, N
    [J]. MYASTHENIA GRAVIS AND RELATED DISEASES: DISORDERS OF THE NEUROMUSCULAR JUNCTION, 1998, 841 : 371 - 387
  • [4] Bennett MW, 1998, J IMMUNOL, V160, P5669
  • [5] Is autoimmunity coming to a Fas(t) end?
    Brunner, T
    Mueller, C
    [J]. NATURE MEDICINE, 1999, 5 (01) : 19 - 20
  • [6] Chattergoon MA, 1998, J IMMUNOL, V160, P5707
  • [7] DEPARAETERE V, 1997, SEMIN IMMUNOL, V9, P93
  • [8] Dichotomy between naive and memory CD4+ T cell responses to Fas engagement
    Desbarats, J
    Wade, T
    Wade, WF
    Newell, MK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (14) : 8104 - 8109
  • [9] AUTOCRINE T-CELL SUICIDE MEDIATED BY APO-1/(FAS/CD95)
    DHEIN, J
    WALCZAK, H
    BAUMLER, C
    DEBATIN, KM
    KRAMMER, PH
    [J]. NATURE, 1995, 373 (6513) : 438 - 441
  • [10] Dudler Jean, 1998, Current Opinion in Rheumatology, V10, P207, DOI 10.1097/00002281-199805000-00009